Table 3.
Comparison of sensitivity, specificity, NPV, and PPV of different AMH threshold values for prediction of OHSS
| Cut-off value | Sensitivity (95% CI) | Specificity (95% CI) | NPV (95% CI) | PPV (95% CI) |
|---|---|---|---|---|
| 2.29 ng/ml | 100% (91.4–100) | 52.3% (41.2–63.4) | 100 (92–100) | 50.6 (39.2–62) |
| 2.53 ng/ml | 92.6% (80.1–98.5) | 57.1% (45.9–67.9) | 94.1 (83.6–98.8) | 51.4 (39.3–63.3) |
| 3.3 ng/ml | 90% (0.77–0.97) | 71% (0.61–0.81) | 94 (0.84–0.98) | 61 (0.47–0.73) |
| 3.88 ng/ml | 75.6% (59.7–87.6) | 78.5% (68.3–86.8) | 86.8 (77.1–93.5) | 63.3 (48.3–76.6) |
| 4.3 ng/ml | 75.6% (59.7–87.6) | 82.1% (72.3–89.6) | 87.3 (77.9–93.8) | 67.4 (52–80.5) |
| 5.07 ng/ml | 56.1% (39.7–71.5) | 88.1% (79.2–94.1) | 80.4 (70.9–88.0) | 69.7 (51.3–84.4) |
| 10.2 ng/ml | 17% (7.2–32.1) | 100% (95.7–100) | 71.2 (62.1–79.2) | 100 (59.0–100) |
AMH antimullerian hormone; NPV negative predictive value; PPV positive predictive value; OHSS ovarian hyperstimulation syndrome